CDH2 and cancer: Our findings highlighted that PRMT6 overexpression significantly elevated the expression of Vimentin, twist, and N-cadherin, while concurrently downregulating E-cadherin expression in cancer cells expressing STAT3 WT, but not in those expressing STAT3 R729K mutant (Fig. 7B, C).